Home / Stocks / OTLK

OTLK insider trading

Outlook Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
9
Bought · 24 mo
$7.9M
Buys · last 90 days
2 · $2.6M
Most recent buy
2026-08-14

Cluster buy detected

5 insiders bought OTLK within a short window (2026-05-26→2026-06-02), $5.3M in total — cluster score 86/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-14GMS Ventures & Investments
Director · 10% owner
Bought2,525,252$0.99$2.5M
2026-07-29Sukhtian Faisal Ghiath
Director
Bought95,398$1.05$100k
2026-06-03Haddadin Yezan Munthercluster
Director
Bought29,000$0.83$24k
2026-06-01GMS Ventures & Investmentscluster
Director · 10% owner
Bought8,539,709$0.59$5.0M
2026-05-27Haddadin Yezan Munthercluster
Director
Bought34,000$0.44$15k
2026-05-27THURMAN RANDY Hcluster
Director
Bought5,000$0.43$2k
2026-05-27HILZINGER KURT Jcluster
Director
Bought400,000$0.44$176k
2026-05-27Sukhtian Faisal Ghiathcluster
Director
Bought122,174$0.41$50k
2024-09-30KENYON LAWRENCE A
Chief Financial Officer
Bought5,000$5.69$28k

Most active insider buyers

InsiderRoleBuysTotal bought
GMS Ventures & InvestmentsDirector · 10% owner2$7.5M
HILZINGER KURT JDirector1$176k
Sukhtian Faisal GhiathDirector2$150k
Haddadin Yezan MuntherDirector2$39k
KENYON LAWRENCE AChief Financial Officer1$28k
THURMAN RANDY HDirector1$2k

See OTLK on the chart

Every insider buy and sell for OTLK plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.